Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(200)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Sep 18, 2024 5:15pm
RE:RE:RE:Market Up...
Everyone is so condescending here and wants to one up Everyone else... self included. And then some here get all bent out of shape if you don't agree with them. Kinda sounds like politics ..
...more
(108)
•••
CaseyL
X
View Profile
View Bullboard History
Comment by
CaseyL
on Sep 18, 2024 3:54pm
RE:RE:Market Up...
Naturally, with your idiocy on display
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(108)
•••
CaseyL
X
View Profile
View Bullboard History
Comment by
CaseyL
on Sep 18, 2024 3:51pm
RE:Market Up...
Quentin you are trash. Notable has no business even responding to you, but he does in great detail.
(96)
•••
Quentin30
X
View Profile
View Bullboard History
Post by
Quentin30
on Sep 18, 2024 3:15pm
Market Up...
ONCY down... Next fireside chat is tomorrow... hands up who thinks the price will rocket after the talk..? Canaduh, can you recall a time where the pps actually rose AFTER an ONCY
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 1:12pm
RE:RE:RE:RE:RE:How does Accelerated Approval work
ONCY is set to run 2 trials in 1 in their planned adaptive designed180-200 Phase2b -> Confirmatory clinical trial - (a pivotal accelerated approval trial powered to a surrogate endpoint and a
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 1:01pm
RE:RE:RE:RE:How does Accelerated Approval work
September 17, 2024 - 21 USC 356: Expedited approval of drugs for serious or life-threatening diseases or conditionsText contains those laws in effect on September 17, 2024 From Title 21
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 12:56pm
RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer
An ASCO Meeting Abstract from the 2022 ASCO Annual Meeting has cited that the average cost for the first year of HR+/HER2 negative was US$192,367 per patient. With ONCY stating that
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 12:53pm
RE:RE:RE:How does Accelerated Approval work
“The accelerated approval program may lower the operational hurdles for launching the above-mentioned products by allowing studies with surrogate endpoints to be reviewed for early approval, in which
...more
(290)
•••
inthno
X
View Profile
View Bullboard History
Comment by
inthno
on Sep 18, 2024 12:51pm
RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
Wow cf and one to talk especially after telling everyone that Matt had exercised 350k options and said that all was good and would not retract that statement. As for the trial cutoff. Kirk clearly
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 12:39pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
"BRACELET-1 substantially de-risks our HR+/HER2- breast cancer program by providing a second randomized dataset showing pelareorep plus paclitaxel outperforming paclitaxel alone
...more
(210)
•••
pelaboost
X
View Profile
View Bullboard History
Post by
pelaboost
on Sep 18, 2024 12:39pm
Accelerated Approval
It was me, from my layman's lair who dug up Accelerated Approval. I was impelled to do so by the rather astonishing results from GOBLET. That is to say, look for a quicker route for pelareorep. I
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 18, 2024 12:36pm
RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
Reposts are necessary for the "goofballs" that you have referenced.
(200)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Sep 18, 2024 12:14pm
RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
Ole unnoteable is so hung up on himself he has to repost his garbage... why get hung up on things we don't know about how the company will do things... it's like listening to all the goofballs
...more
(964)
•••
canadafan
X
View Profile
View Bullboard History
Comment by
canadafan
on Sep 18, 2024 12:11pm
RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
For some reason mr. Qu30, keeps stating " they have the data" Unless, he/ she is part if the trial clinics & evaluating teams, there is 100% no way to prove or unproven " they have
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer